Pure Global

familyDr. HbA1c (Glycated Hemoglobin) Rapid Quantitative Test (Immunofluorescence Assay) - Indonesia BPOM Medical Device Registration

familyDr. HbA1c (Glycated Hemoglobin) Rapid Quantitative Test (Immunofluorescence Assay) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20207420172. The device is manufactured by AEHEALTH LIMITED from United Kingdom, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. MEDISINDO BAHANA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
familyDr. HbA1c (Glycated Hemoglobin) Rapid Quantitative Test (Immunofluorescence Assay)
Analysis ID: AKL 20207420172

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Manufacturer

AEHEALTH LIMITED

Country of Origin

United Kingdom

Authorized Representative

PT. MEDISINDO BAHANA

AR Address

GRAHA CEMPAKA MAS BLOK D No. 9 & Blok E NO.15 JL. LETJEN SUPRAPTO SUMUR BATU

Registration Date

Oct 21, 2024

Expiry Date

Aug 01, 2028

Product Type

Haematology Package and Kit

Glycosylated hemoglobin assay.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing